Skip to main content

Table 5 Summary of results from the item selection process

From: A multi-method approach to selecting PRO-CTCAE symptoms for patient-reported outcome in women with endometrial or ovarian cancer undergoing chemotherapy

MedDRA system organ classes1

Identified PRO-CTCAE symptoms based on two core outcome sets2,3

Identified symptoms from product summaries and phase III clinical studies4,5,6, aligned with matching PRO-CTCAE symptoms7

Final PRO-CTCAE symptoms7 included in the PRO tool

Gastrointestinal disorders

 

Constipation

Constipation

Constipation

 

Diarrhea

Diarrhea

Diarrhea

 

Nausea

Nausea

Nausea

 

Bloating

Mouth/throat sores

Mouth/throat sores

 

Vomiting

Vomiting

Vomiting

   

Bloating

General disorders and administration site conditions

 

Fatigue

Fatigue

Fatigue

 

Abdominal pain

General pain

Abdominal pain

Metabolism and nutrition disorders

 

Decreased appetite

Decreased appetite

Decreased appetite

Musculoskeletal and connective tissue disorders

  

Joint pain

Joint pain

  

Muscle pain

Muscle pain

Nervous system disorders

 

Numbness & tingling

Numbness & tingling

Numbness & tingling

Psychiatric disorders

 

Anxious

 

Anxious

 

Concentration

 

Concentration

 

Discouraged

 

Discouraged

 

Memory

 

Insomnia

 

Insomnia

 

Memory

 

Sad

 

Sad

Reproductive system and breast disorders

 

Sexual dysfunction

 

Decreased libido

 

Vaginal dryness

 

Vaginal dryness

Respiratory, thoracic and mediastinal disorders

 

Shortness of breath

Shortness of breath

Shortness of breath

Skin and subcutaneous tissue disorders

  

Hair loss

 
  

Nail loss

 
  

Nail ridging

 
  

Nail discoloration

 
  

Rash

 

Investigations

  

Taste changes

 

Unique symptoms, total

18

18

21

  1. PRO-CTCAE Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events, MedDRA Medical Dictionary for Regulatory Activities
  2. 1Medical Dictionary for Regulatory Activities (MedDRA) [Internet]. Available from: https://www.meddra.org/ (39), 2Reeve et al. [41], 3Donovan et al. [42], 4Du Bois et al.[48], 5Ozols et al. [47], 6Vasey et al. [46], 7PRO-CTCAE. PRO-CTCAE® Measurement System website [Internet]. Available from: https://healthcaredelivery.cancer.gov/pro-ctcae/ [17]